No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs567675229 |
chr13:111378194-111378195 |
Weak transcription Genic enhancers Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs534665646 |
chr13:111378199-111378200 |
Weak transcription Genic enhancers Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs72663423 |
chr13:111378205-111378206 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs527324023 |
chr13:111378261-111378262 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs538747573 |
chr13:111378272-111378273 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs143548872 |
chr13:111378286-111378287 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs371022883 |
chr13:111378328-111378329 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs192699831 |
chr13:111378356-111378357 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs151279473 |
chr13:111378417-111378418 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs560167369 |
chr13:111378484-111378485 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs529838501 |
chr13:111378511-111378512 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs376072303 |
chr13:111378518-111378519 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs576666904 |
chr13:111378521-111378522 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs573582666 |
chr13:111378544-111378545 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs540626295 |
chr13:111378572-111378573 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs559378810 |
chr13:111378576-111378577 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs2038952 |
chr13:111378652-111378653 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs184319552 |
chr13:111378724-111378725 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs563507914 |
chr13:111378788-111378789 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs563175918 |
chr13:111378873-111378874 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs189602268 |
chr13:111378999-111379000 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs181209279 |
chr13:111379042-111379043 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs139280929 |
chr13:111379078-111379079 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs2033947 |
chr13:111379089-111379090 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs184971953 |
chr13:111379106-111379107 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs115168878 |
chr13:111379110-111379111 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs547890005 |
chr13:111379127-111379128 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs76616334 |
chr13:111379131-111379132 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs188938152 |
chr13:111379209-111379210 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs557003175 |
chr13:111379228-111379229 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs569128656 |
chr13:111379260-111379261 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs146898350 |
chr13:111379263-111379264 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs555250546 |
chr13:111379270-111379271 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs368446961 |
chr13:111379273-111379274 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs117447571 |
chr13:111379274-111379275 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs540918791 |
chr13:111379303-111379304 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs181631343 |
chr13:111379314-111379315 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs577695256 |
chr13:111379326-111379327 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs527268711 |
chr13:111379327-111379328 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs534476074 |
chr13:111379352-111379353 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs2165418 |
chr13:111379365-111379366 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
42 |
rs147780604 |
chr13:111379375-111379376 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs530743842 |
chr13:111379424-111379425 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs368061624 |
chr13:111379444-111379445 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs35427744 |
chr13:111379480-111379481 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs570276462 |
chr13:111379631-111379632 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs561133718 |
chr13:111379642-111379643 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs528406651 |
chr13:111379652-111379653 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs570781589 |
chr13:111379710-111379711 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs539246200 |
chr13:111379736-111379737 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|